CRWV Insider Notice: $38.64M Block Sale Planned via Morgan Stanley

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) Form 144 notice reports a planned sale of 375,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $38,640,000, and lists 370,470,348 shares outstanding. The shares to be sold were acquired as founders' shares on 11/13/2017. The filing also discloses recent Rule 10b5-1 executed sales by related parties: two sales of 375,000 and two sales of 250,000 common shares on 08/19/2025 and 08/26/2025, generating gross proceeds shown for each transaction. The filer affirms they are not aware of undisclosed material adverse information in the issuer.

Positive

• Disclosure of planned sale specifies broker, share count, and aggregate market value providing transparency
• Acquisition details show the shares were founders' shares acquired on 11/13/2017, clarifying provenance
• Recent 10b5-1 sales disclosed indicate adherence to prearranged trading plans rather than opportunistic trades
• Filer representation that no undisclosed material adverse information is known offers standard regulatory assurance

Negative

• Insider liquidity: multiple sizable 10b5-1 sales in August and a planned sale may increase supply pressure on the stock
• Material size: the planned 375,000-share sale equals a meaningful cash amount ($38.64M) even if a small percentage of outstanding shares

Insights

Securities Analyst

TL;DR: Insider-linked block sale disclosed; size material relative to outstanding shares but appears executed under Rule 10b5-1 plans.

The filing shows an intended block sale of 375,000 founder shares via a broker at an indicated aggregate market value of $38.64 million against 370.47 million shares outstanding, representing roughly 0.10% of outstanding stock. Multiple 10b5-1 sales by the same beneficial owners earlier in August are reported with stated gross proceeds. From a securities-analyst view, these are controlled dispositions consistent with prearranged trading plans rather than open-market ad-hoc dispositions, though the filings do indicate ongoing insider liquidity.

Corporate Governance Expert

TL;DR: Governance disclosure is routine and compliant; the filer affirms no undisclosed material information.

The Form 144 provides the required particulars: class, broker, number of shares, acquisition origin (founders' shares), and recent aggregated 10b5-1 sales by related parties. The representation that no material adverse information is undisclosed is standard. There is no indication in the document of atypical governance actions or regulatory issues. The pattern of planned and executed 10b5-1 sales suggests planned liquidity events rather than reactive insider trading.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	375000	38640000.00	370470348	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			375000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Livingston NJ 07039	Common	08/26/2025	250000	22996925.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Livingston NJ 07039	Common	08/26/2025	375000	34495387.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Livingston NJ 07039	Common	08/19/2025	250000	22926475.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Livingston NJ 07039	Common	08/19/2025	375000	34389712.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is the size of the planned sale reported on the Form 144 for CRWV?

The Form 144 reports a planned sale of 375,000 common shares with an aggregate market value of $38,640,000.

Who is acting as broker for the proposed CRWV sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY.

When were the shares being sold originally acquired?

The shares to be sold were acquired as founders' shares on 11/13/2017.

Have there been other recent insider sales reported for CRWV?

Yes. The filing lists four 10b5-1 sales in August 2025: two of 375,000 shares and two of 250,000, with gross proceeds reported for each transaction.

What percentage of outstanding shares does the planned sale represent?

The filing lists 370,470,348 shares outstanding; 375,000 shares represent roughly 0.10% of outstanding shares.